BioCentury
ARTICLE | Clinical News

Abelcet liposomal amphotericin B regulatory update

November 8, 1999 8:00 AM UTC

Turkey granted marketing approval to LIPO's Abelcet to treat invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy. ...